Effects of dacomitinib on the pharmacokinetics of poziotinib in vivo and in vitro
Context Dacomitinib and poziotinib, irreversible ErbB family blockers, are often used for treatment of non-small cell lung cancer (NSCLC) in the clinic. Objective This study investigates the effect of dacomitinib on the pharmacokinetics of poziotinib in rats. Materials and methods Twelve Sprague-Daw...
Saved in:
Main Authors: | Weiping Ji (Author), Jiquan Shen (Author), Bo Wang (Author), Feifei Chen (Author), Deru Meng (Author), Shuanghu Wang (Author), Dapeng Dai (Author), Yunfang Zhou (Author), Changxiong Wang (Author), Quan Zhou (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition and Induction by Poziotinib of Different Rat Cytochrome P450 Enzymes In Vivo and in an In Vitro Cocktail Method
by: Jinhui Wang, et al.
Published: (2021) -
Effects of naringenin on the pharmacokinetics of tofacitinib in rats
by: Bo Wang, et al.
Published: (2020) -
Inhibitory Effect of Imperatorin on the Pharmacokinetics of Diazepam In Vitro and In Vivo
by: Yunfang Zhou, et al.
Published: (2020) -
Effects of bergapten on the pharmacokinetics of macitentan in rats both in vitro and in vivo
by: Jia Xu, et al.
Published: (2023) -
Assessments of CYP‑inhibition‑based drug-drug interaction between vonoprazan and poziotinib in vitro and in vivo
by: Shan Zhou, et al.
Published: (2023)